Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Multi Ways Holdings Limited | MWG | Apr 26, 2024 | 0.34 | -5.56 |
MultiPlan A | MPLN | Apr 26, 2024 | 0.58 | +0.82 |
MultiSensor AI | MSAI | Apr 26, 2024 | 2.73 | 0.00 |
Mural Oncology | MURA | Apr 26, 2024 | 3.58 | +1.42 |
Murano Global Investments | MRNO | Apr 26, 2024 | 7.97 | 0.00 |
Murphy Oil | MUR | Apr 26, 2024 | 46.44 | +0.02 |
Murphy USA | MUSA | Apr 26, 2024 | 421.34 | +0.19 |
Mustang Bio | MBIO | Apr 26, 2024 | 0.32 | -9.79 |
MV Oil Royalty Trust | MVO | Apr 26, 2024 | 9.73 | -1.62 |
MVB Financial | MVBF | Apr 26, 2024 | 19.64 | -0.41 |
My Size | MYSZ | Apr 26, 2024 | 3.70 | +8.82 |
Myers Industries | MYE | Apr 26, 2024 | 22.04 | +0.05 |
MyMD Pharmaceuticals | MYMD | Apr 26, 2024 | 2.84 | +1.07 |
Mynaric ADR | MYNA | Apr 26, 2024 | 5.79 | -0.86 |
Myomo | MYO | Apr 26, 2024 | 3.43 | +0.29 |
MYR Group | MYRG | Apr 26, 2024 | 168.16 | +1.26 |
Myriad Genetics | MYGN | Apr 26, 2024 | 18.18 | +1.11 |
MYT Netherlands Parent ADR | MYTE | Apr 26, 2024 | 4.14 | -0.24 |
N-able | NABL | Apr 26, 2024 | 12.40 | +1.47 |
N2OFF | NITO | Apr 26, 2024 | 1.09 | 0.00 |
NaaS Technology ADR | NAAS | Apr 26, 2024 | 0.96 | +5.72 |
Nabors Energy Transition II | NETD | Apr 26, 2024 | 10.49 | +0.05 |
Nabors Energy Transition II | NETDU | Apr 26, 2024 | 10.54 | 0.00 |
Nabors Industries | NBR | Apr 26, 2024 | 77.20 | +1.26 |
NACCO Industries | NC | Apr 26, 2024 | 28.15 | -1.30 |
Nano Dimension ADR | NNDM | Apr 26, 2024 | 2.45 | -0.41 |
Nano Labs | NA | Apr 26, 2024 | 0.48 | +19.32 |
Nano-X Imaging | NNOX | Apr 26, 2024 | 8.96 | +0.45 |
Nanobiotix ADR | NBTX | Apr 26, 2024 | 5.74 | -2.88 |
NanoVibronix | NAOV | Apr 26, 2024 | 0.76 | +1.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.